Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
A fold-change (FC) 1.2 or FC 0.83 in the experimental group compared with that in the control group was considered as up- or downregulation of phospho-specific proteins
Recalls & Warnings February 20, 2013 Recall: Arthritis and Muscle Pain Supplement Contains Prescription Drugs On February 15, 2013, Reumofan Plus USA, LLC and Reumofan USA, LLC announced a recall of Reumofan Plus, a dietary supplement promoted for arthritis and muscle pain, because it was found to contain the active pharmaceutical ingredients methocarbamol, dexamethasone, and diclofenac
Exposure to light, heat, and air can degrade the solution, reducing its effectiveness
Patterson and his staff are knowledgeable and very thorough
All studies must be conducted by qualified professionals in certified laboratory settings under appropriate ethical and safety protocols
